Skip to content
Sunday, November 22, 2026
Latest
Market Indonesia

Vape study finds 240ml lung function drop in heavy users

A small pilot study in Tobacco Control reports that vapers aged 21 to 35 who used their device 30 or more times a day saw FEV1 fall by as much as 240 millilitres after a year. The study researchers and Dr. Mina Makaryus link sustained declines to a higher risk of COPD, an incurable disease.

Test tubes used in a laboratory for chemical analysis
Test tubes used in a laboratory for chemical analysis. Photographed 2012-08-15. File photo: Sarka Na kopci / Wikimedia Commons, CC BY-SA 4.0. Image: Sarka Na kopci Image source · CC BY-SA 4.0 · Display crop and size variants; source image content retained.

Key points

  • A pilot study in Tobacco Control found vapers aged 21 to 35 who used their device 30 or more times daily saw FEV1 fall by up to 240 millilitres after one year, according to Antara.
  • Dr. Mina Makaryus said the small-scale study should be treated as a warning that vaping may not be as safe as assumed.
  • Sustained lung function decline is linked to a higher risk of COPD, a progressive and incurable disease, according to the report.
  • Makaryus said some patients improved after they stopped vaping and advised users to consult a doctor about nicotine dependence.
  • The report does not state the study's sample size, the device or e-liquid involved, or the Tobacco Control publication date.
On this page
  1. Heavy users saw the sharpest FEV1 loss
  2. Clinicians are being asked to discuss nicotine dependence
  3. What the findings change for the supply chain
  4. Indonesia’s fatwa context sits alongside the study
  5. Questions readers ask

A pilot study published in Tobacco Control has found that vapers aged 21 to 35 who used their device 30 or more times a day experienced a decline in forced expiratory volume in one second (FEV1) of up to 240 millilitres after one year, according to Antara. The report was relayed by Dr. Mina Makaryus, director of the Asthma Center at Northwell Health’s North Shore University Hospital and Long Island Jewish Medical Center.

The finding is an early-stage result from a small study, Makaryus said, and she urged vapers not to dismiss it.

Heavy users saw the sharpest FEV1 loss

Among participants who puffed 30 or more times daily, FEV1 fell by 240 millilitres, according to the study as reported by Antara. FEV1 measures the volume of air a person can forcibly exhale in one second.

A sustained decline in lung function is linked to a higher risk of chronic obstructive pulmonary disease (COPD), a progressive and incurable condition that makes breathing difficult, according to the report. Makaryus said that even within the one-year study period, the statistically significant drop suggested that lung function would likely continue to fall if the same patients were followed for longer.

She also said her clinical practice has included vape users with a history of asthma or COPD, and she noted an association between vaping and worsening lung disease in those patients. Some patients improved after they stopped vaping, she said. Makaryus cautioned that long-term inhalation of vape substances that reduce lung function could lead to permanent lung injury similar to COPD.

The report does not state the size of the study sample, the device type or e-liquid used, or the publication date of the Tobacco Control paper. Those details are not available in the source material.

Clinicians are being asked to discuss nicotine dependence

Makaryus advised vapers to consult a doctor about managing nicotine dependence and about alternatives to nicotine, vaping and cigarettes. She framed this as a warning that other options exist for addressing nicotine addiction, according to the report. She did not recommend a specific product or treatment in the report.

What the findings change for the supply chain

Analysis: the study gives manufacturers and distributors in the Shenzhen supply chain another piece of published health evidence to consider in product documentation and market communication, though the report does not name any device, brand or e-liquid. The absence of product-level detail limits what the findings can support in regulatory submissions or labelling claims. The report also does not identify a regulator action, so no compliance deadline follows directly from it.

Indonesia’s fatwa context sits alongside the study

The Antara report links to a separate item on the Indonesian Ulema Council (MUI) issuing a fatwa declaring vape haram and asking the government to draft regulation, but the source text does not give the fatwa’s date, status or scope. Neither that linked item nor the health study establishes a national ban.

Makaryus’s advice to consult a physician is the only practical step the report attributes to a named clinician. The study’s sample size and the Tobacco Control publication date remain unconfirmed in the source material; readers should treat the 240 millilitre figure as a result from a small pilot study rather than a population-level estimate.

Questions readers ask

How much did FEV1 fall in the study?

Vapers who used their device 30 or more times a day saw FEV1 fall by up to 240 millilitres after one year, according to Antara's report on the Tobacco Control study.

Who conducted the study?

The study was published in the journal Tobacco Control, but the source material does not name the authors, the institution or the sample size.

Did the study find a link to COPD?

The report says sustained lung function decline can raise the risk of chronic obstructive pulmonary disease (COPD), a progressive and incurable condition. Dr. Mina Makaryus said some of her patients with asthma or COPD improved after stopping vaping.

Share

Sources

18+ only. This site is for adult readers and provides news and information only. It is not medical, legal or purchase advice. Nicotine is addictive. Always check the official text of any regulation in your market. Health Information

VapeBrief Markets Desk

A shared VapeBrief publication label for market, industry and trade-event coverage, not a named person or a claim about team size or professional qualifications.

About this byline →

Daily Brief newsletter

A concise email at 08:00 U.S. Eastern time each day, with links to the previous day’s published briefs.

Topics of interest

Active immediately, no confirmation click needed. Every email includes an unsubscribe link. See our Privacy Policy.